Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RalBP1-associated Eps domain-containing protein 2 (REPS2) is a protein product encoded by the REPS2 gene. It functions as part of a protein complex that regulates the endocytosis of growth factor receptors, interacting directly with a GTPase activating protein downstream of the small G protein Ral. Through these interactions, REPS2 may influence receptor internalization and growth factor signaling, as well as cell adhesion and migration via connections with ASAP1. Multiple isoforms of REPS2 exist due to alternative splicing. REPS2 is downregulated in prostate cancer progression and is associated with diseases such as Nance-Horan Syndrome and autism spectrum disorder. The protein interacts with EPN1, EPS15, RALBP1, but is not currently recognized as a direct therapeutic target, and no drugs are known to interact with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RalBP1-associated Eps domain-containing protein 2 (REPS2).